Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0W0WU
|
|||
Former ID |
DIB008858
|
|||
Drug Name |
Diethylnorspermine
|
|||
Synonyms |
BENSPM; DENSPM; BE-333; DE-333; N1,N11-Diethylnorspermine; N1,N11-Bis(ethyl)norspermine; 1,11-Bis(ethylamino)-4,8-diazaundecane
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
Company |
Genzyme
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H32N4
|
|||
Canonical SMILES |
CCNCCCNCCCNCCCNCC
|
|||
InChI |
1S/C13H32N4/c1-3-14-8-5-10-16-12-7-13-17-11-6-9-15-4-2/h14-17H,3-13H2,1-2H3
|
|||
InChIKey |
UMJJGDUYVQCBMC-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 121749-39-1
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5922-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.